Literature summary for 2.1.1.357 extracted from

Shen, Y.; Morishita, M.; di Luccio, E.
High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag (2020), Protein Expr. Purif., 166, 105506 .

Search for more literature for 2.1.1.357

Application

Application	Comment	Organism
synthesis	expression of NSDs via tagging with a human influenza hemagglutinin tag greatly improves the quality of the recombinant NSDs, resulting in more than 95% pure, stable, and active NSD-hemagglutinins, with an increase in production yield up to 22.4fold and up to 6.25 mg/l from LB Eschewrichia coli culture, and without further purification	Homo sapiens

Cloned(Commentary)

Cloned (Comment)	Organism
development of a modified Escherichia coli expression system	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	Q96L73	isoform NSD1	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)